paxista  is an investigational antiviral therapy drug with active ingredients Nirmatrivir 150 MG and Ritonavir 100 MG approved for emergency use. This drug is indicated for the treatment of mild-to-moderate coronavirus disease in adults and pediatric patients (12 years and weight > 40 kg) who test positive.